- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06538038
Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
Prospective Non-Interventional Study Comparing Standard of Care Osimertinib +/- Chemotherapy for EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC) Patients
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study tests the feasibility of using real-world data collection through the recruitment of well-characterized patients into a registry, spanning academic and community practice sites to determine patient outcomes in all-comers. The scientific community would further benefit from a greater understanding of the safety and effectiveness of newly approved therapies prescribed in routine clinical practice.
Non-interventional (observational) study with 250 participants per exposure group (maximum accrual up to 538 total participants) comparing outcomes in patients with EGFR-mutated NSCLC, not being treated in a clinical trial but receiving standard of care osimertinib +/- chemotherapy.
The treating physician determines whether a patient will receive standard of care single agent osimertinib or osimertinib with chemotherapy and the planned treatment is recorded at registration.
Clinical/Imaging assessments will be per the treating physician.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Alabama
-
Birmingham, Alabama, United States, 35294
- University of Alabama at Birmingham
-
-
Arkansas
-
Fort Smith, Arkansas, United States, 72903
- Mercy Research
-
Fort Smith, Arkansas, United States, 72903
- Mercy Clinic Fort Smith Communities
-
Jonesboro, Arkansas, United States, 72401
- Fowler Family Cancer Center - Jonesboro
-
-
California
-
Emeryville, California, United States, 94608
- Stanford Cancer Center Emeryville
-
Palo Alto, California, United States, 94304
- Stanford Cancer Institute Palo Alto
-
San Jose, California, United States, 95124
- Stanford Cancer Center South Bay
-
Walnut Creek, California, United States, 94598
- John Muir Health
-
-
Delaware
-
Dover, Delaware, United States, 19901
- Bayhealth
-
Milford, Delaware, United States, 19901
- Satellite of Bayhealth Sussex
-
-
District of Columbia
-
Washington D.C., District of Columbia, United States, 20016
- Sibley Johns Hopkins University
-
-
Georgia
-
Hinesville, Georgia, United States, 31313
- Lewis Cancer and Research Pavilion at Saint Joseph's/Candler: Liberty County Cancer Care
-
Jesup, Georgia, United States, 31545
- Lewis Cancer and Research Pavilion at Saint Joseph's/Candler: Regional Cancer Care
-
Savannah, Georgia, United States, 31405
- Lewis Cancer and Research Pavilion at Saint Joseph's/Candler
-
-
Illinois
-
Barrington, Illinois, United States, 60010
- Advocate Good Shepherd Hospital
-
Chicago, Illinois, United States, 60611
- Northwestern University
-
Chicago, Illinois, United States, 60612
- John H Stroger Jr Hospital of Cook County
-
Chicago, Illinois, United States, 60657
- Advocate Illinois Masonic Medical Center
-
DeKalb, Illinois, United States, 60115
- Northwestern Medicine Cancer Center Kishwaukee
-
Geneva, Illinois, United States, 60134
- Northwestern Medicine Cancer Center Delnor
-
Glenview, Illinois, United States, 60026
- Northwestern Medicine Glenview Outpatient Center
-
Grayslake, Illinois, United States, 60030
- Northwestern Medicine Grayslake Outpatient Center
-
Hazel Crest, Illinois, United States, 60429
- Advocate South Suburban Hospital
-
Lake Forest, Illinois, United States, 60045
- Northwestern Medicine Lake Forest Hospital
-
Normal, Illinois, United States, 61761
- Carle Cancer Institute Normal
-
Oak Lawn, Illinois, United States, 60453
- Advocate Christ Medical Center
-
Orland Park, Illinois, United States, 60462
- Northwestern Medicine Orland Park
-
Park Ridge, Illinois, United States, 60068
- Advocate Lutheran General Hospital
-
Urbana, Illinois, United States, 61801
- Carle Founation Hospital
-
Warrenville, Illinois, United States, 60555
- Northwestern Medicine Cancer Center Warrenville
-
-
Maryland
-
Baltimore, Maryland, United States, 21204
- Greater Baltimore Medical Center
-
Baltimore, Maryland, United States, 21201
- University of Maryland Greenebaum Comprehensive Cancer Center
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02111
- Tufts Medical Center
-
Lowell, Massachusetts, United States, 01854
- Lowell General Hosptial
-
Stoneham, Massachusetts, United States, 02180
- Tufts Medical Center Cancer Center Stoneham
-
-
Minnesota
-
Burnsville, Minnesota, United States, 55337
- Minnesota Oncology - Burnsville
-
Cambridge, Minnesota, United States, 55008
- Cambridge Medical Center
-
Coon Rapids, Minnesota, United States, 55433
- Mercy Hospital
-
Edina, Minnesota, United States, 55435
- Fairview Southdale Hospital
-
Maple Grove, Minnesota, United States, 55369
- Fairview Clinics and Surgery Center Maple Grove
-
Maplewood, Minnesota, United States, 55109
- Saint John's Hospital - Healtheast
-
Maplewood, Minnesota, United States, 55109
- Minnesota Oncology Hematology PA-Maplewood
-
Minneapolis, Minnesota, United States, 55415
- Hennepin County Medical Center
-
Minneapolis, Minnesota, United States, 55407
- Abbott-Northwestern Hospital
-
Minneapolis, Minnesota, United States, 55454
- Health Partners Inc.
-
Monticello, Minnesota, United States, 55362
- Monticello Cancer Center
-
New Ulm, Minnesota, United States, 56073
- New Ulm Medical Center
-
Princeton, Minnesota, United States, 55371
- Fairview Northland Medical Center
-
Robbinsdale, Minnesota, United States, 55422
- North Memorial Medical Health Center
-
Saint Louis Park, Minnesota, United States, 55416
- Park Nicollet Clinic - Saint Louis Park
-
Saint Louis Park, Minnesota, United States, 55426
- Metro MN
-
Saint Paul, Minnesota, United States, 55101
- Regions Hospital
-
Saint Paul, Minnesota, United States, 55102
- United Hospital
-
Shakopee, Minnesota, United States, 55379
- Saint Francis Regional Medical Center
-
Stillwater, Minnesota, United States, 55082
- Lakeview Hospital
-
Waconia, Minnesota, United States, 55387
- Ridgeview Medical Center
-
Willmar, Minnesota, United States, 56201
- Rice Memorial Hospital
-
Woodbury, Minnesota, United States, 55125
- Minnesota Oncology Hematology PA-Woodbury
-
Wyoming, Minnesota, United States, 55092
- Fairview Lakes Medical Center
-
-
Mississippi
-
Columbus, Mississippi, United States, 39705
- Baptist Memorial Hospital and Cancer Center - Golden Triangle
-
Grenada, Mississippi, United States, 38901
- Baptist Cancer Center - Grenada
-
Jackson, Mississippi, United States, 39202
- Jackson Oncology Associates PLLC
-
Jackson, Mississippi, United States, 39202
- Mississippi Baptist Medical Center
-
New Albany, Mississippi, United States, 38652
- Baptist Memorial Hospital and Cancer Center - Union
-
Oxford, Mississippi, United States, 38655
- Baptist Memorial Hospital and Cancer Center - Oxford
-
Southhaven, Mississippi, United States, 38671
- Baptist Memorial Hospital and Cancer Center - Desoto
-
-
Missouri
-
Joplin, Missouri, United States, 64804
- Mercy Clinic Joplin, LLC
-
Rolla, Missouri, United States, 65401
- Mercy Clinic Cancer and Hematology
-
Springfield, Missouri, United States, 65804
- Mercy Clinic Springfield Communities
-
St Louis, Missouri, United States, 63128
- Mercy Clinic East Communities
-
St Louis, Missouri, United States, 63141
- Mercy Clinic East Communities
-
-
New Jersey
-
Moorestown, New Jersey, United States, 08057
- Virtua Samson Cancer Center
-
Morristown, New Jersey, United States, 07960
- Morristown Medical Center
-
Morristown, New Jersey, United States, 07960
- Atlantic Health Cancer Consortium Community Oncology Research Program
-
New Brunswick, New Jersey, United States, 08903
- Rutgers Cancer Institute of New Jersey
-
Paramus, New Jersey, United States, 07652
- The Valley Hospital - Luckow Pavilion
-
Sewell, New Jersey, United States, 08080
- Sidney Kimmel Cancer Center Washington Township
-
Summit, New Jersey, United States, 07901
- Overlook Medical Center
-
Voorhees Township, New Jersey, United States, 08043
- Virtua Voorhees
-
-
New York
-
East Hills, New York, United States, 11548
- The Cancer Institute at St. Francis Hospital
-
New York, New York, United States, 10467
- Montefiore
-
Syracuse, New York, United States, 13210
- SUNY Upstate Medical University
-
The Bronx, New York, United States, 10461
- Montefiore Medical Center-Einstein Campus
-
West Islip, New York, United States, 11795
- Good Samaritan University Hospital
-
-
North Carolina
-
Hendersonville, North Carolina, United States, 28791
- UNC Pardee Cancer Center
-
Pinehurst, North Carolina, United States, 28374
- FirstHealth of the Carolinas-Moore Regional Hospital
-
-
Ohio
-
Canton, Ohio, United States, 44710
- Aultman
-
Centerville, Ohio, United States, 45459
- Miami Valley Hospital South
-
Englewood, Ohio, United States, 45415
- Miami Valley Hospital North
-
Franklin, Ohio, United States, 45005
- Atrium Medical Center-Middletown Regional Hospital
-
Greenville, Ohio, United States, 45331
- Miami Valley Cancer Care and Infusion
-
Troy, Ohio, United States, 45373
- Upper Valley Medical Center
-
-
Oklahoma
-
Oklahoma City, Oklahoma, United States, 73120
- Mercy Clinic Oklahoma Communities, Inc.
-
-
Pennsylvania
-
Danville, Pennsylvania, United States, 17822
- Geisinger Medical Center
-
Hazleton, Pennsylvania, United States, 18201
- Geisinger Medical Center-Cancer Center Hazleton
-
Lewisburg, Pennsylvania, United States, 17837
- Geisinger Medical Oncology-Lewisburg
-
Lewistown, Pennsylvania, United States, 17044
- Lewistown Hospital
-
Paoli, Pennsylvania, United States, 19301
- Lankenau Medical Center
-
Philadelphia, Pennsylvania, United States, 19104
- University of Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19107
- Thomas Jefferson University Hospital
-
Philadelphia, Pennsylvania, United States, 19114
- Jefferson Torresdale Hospital
-
Philadelphia, Pennsylvania, United States, 19141
- Einstein Medical Center
-
Pittsburgh, Pennsylvania, United States, 15212
- Allegheny General Hospital
-
Pottsville, Pennsylvania, United States, 17901
- Geisinger Cancer Services-Pottsville
-
Scranton, Pennsylvania, United States, 18510
- Community Medical Center
-
State College, Pennsylvania, United States, 16801
- Geisinger Medical Group
-
Wilkes-Barre, Pennsylvania, United States, 18711
- Geisinger Wyoming Valley/Henry Cancer Center
-
Willow Grove, Pennsylvania, United States, 19090
- Asplundh Cancer Pavilion
-
-
South Carolina
-
Bluffton, South Carolina, United States, 29910
- Lewis Cancer and Research Pavilion at Saint Joseph's/Candler: SJC Bluffton Campus
-
Hilton Head Island, South Carolina, United States, 29926
- Lewis Cancer and Research Pavilion at Saint Joseph's/Candler: South Carolina Cancer Specialists
-
-
Tennessee
-
Collierville, Tennessee, United States, 38017
- Baptist Memorial Hospital and Cancer Center - Collierville
-
Memphis, Tennessee, United States, 38120
- Baptist Memorial Hospital for Women
-
Memphis, Tennessee, United States, 38120
- Baptist Memorial Hospital and Cancer Center - Memphis
-
Nashville, Tennessee, United States, 37232
- Vanderbilt University
-
-
Texas
-
Dallas, Texas, United States, 75235
- UT Southwest
-
Fort Worth, Texas, United States, 76104
- JPS Oncology & Infusion Center
-
-
Wisconsin
-
Appleton, Wisconsin, United States, 54911
- ThedaCare Regional Cancer Center
-
Appleton, Wisconsin, United States, 54911
- ThedaCare Regional Medical Center - Appleton
-
Berlin, Wisconsin, United States, 54923
- ThedaCare Cancer Care - Berlin
-
Burlington, Wisconsin, United States, 53105
- Aurora Cancer Care-Southern Lakes VLCC
-
Cudahy, Wisconsin, United States, 53110
- Aurora Saint Luke's South Shore
-
Germantown, Wisconsin, United States, 53022
- AHC Germantown Health Center
-
Grafton, Wisconsin, United States, 53024
- Aurora Cancer Care-Grafton
-
Green Bay, Wisconsin, United States, 54311
- Aurora BayCare Medical Center
-
Janesville, Wisconsin, United States, 53548
- Mercyhealth Hospital and Cancer Center - Janesville
-
Kenosha, Wisconsin, United States, 53142
- Aurora Cancer Care-Kenosha South
-
La Crosse, Wisconsin, United States, 54601
- Gundersen Lutheran Medical Foundation
-
Madison, Wisconsin, United States, 53715
- University of Wisconsin Carbone Cancer Center
-
Marshfield, Wisconsin, United States, 54449
- Marshfield Medical Center
-
Milwaukee, Wisconsin, United States, 53209
- Aurora Cancer Care-Milwaukee
-
Milwaukee, Wisconsin, United States, 53215
- Aurora Saint Luke's Medical Center
-
Milwaukee, Wisconsin, United States, 53233
- Aurora Sinai Medical Center
-
Milwaukee, Wisconsin, United States, 53227
- Aurora West Allis Medical Center
-
Milwaukee, Wisconsin, United States, 53215
- Aurora NCORP
-
Neenah, Wisconsin, United States, 54956
- ThedaCare Regional Medical Center - Neenah
-
New London, Wisconsin, United States, 54961
- ThedaCare Cancer Care - New London
-
Oshkosh, Wisconsin, United States, 54904
- ThedaCare Cancer Care - Oshkosh
-
Oshkosh, Wisconsin, United States, 54904
- Vince Lombardi Cancer Clinic-Oshkosh
-
Racine, Wisconsin, United States, 53406
- Aurora Cancer Care-Racine
-
Shawano, Wisconsin, United States, 54166
- ThedaCare Cancer Care - Shawano
-
Sheboygan, Wisconsin, United States, 53081
- Vince Lombardi Cancer Clinic-Sheboygan
-
Summit, Wisconsin, United States, 53066
- Aurora Medical Center in Summit
-
Two Rivers, Wisconsin, United States, 54241
- Vince Lombardi Cancer Clinic-Two Rivers
-
Waukesha, Wisconsin, United States, 53022
- ProHealth
-
Waupaca, Wisconsin, United States, 54981
- ThedaCare Cancer Care - Waupaca
-
Wauwatosa, Wisconsin, United States, 53226
- Aurora Cancer Care-Milwaukee West
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patient must have a pathologically-confirmed diagnosis of non-small cell lung cancer (NSCLC).
- Patient must have advanced disease, defined as IIIB (not amenable to definitive multi-modality therapy), IIIC, or IV (includes local or distant recurrent disease after a prior diagnosis of Stage I-III disease). All staging is via the American Joint Committee on Cancer (AJCC)/International Association for the Study of Lung Cancer (IASLC) 8th edition staging criteria.
- Patient tumor must have somatic activating sensitizing mutation in EGFR (e.g., but not limited to Exon 19 deletion, L858R, E709X, G719X, exon 19 insertions, L861Q, S768I). Patients with non-sensitizing mutations in EGFR (EGFR exon 20 insertions) are not eligible. Plasma, cytology, or tumor tissue can be utilized for standard of care mutation testing.
- Prior chemotherapy and/or immunotherapy administered as primary treatment for NSCLC before EGFR mutation was identified is allowed ≤ 45 days of study registration to allow for return of sequencing information.
- Prior treatment with osimertinib administered as primary treatment for NSCLC is allowed ≤ 30 days of study registration (prior treatment with any other EGFR TKI agent is not allowed).
- Patient must not be participating in EA5182 or any other cancer treatment trial. Osimertinib or osimertinib + chemotherapy/immunotherapy given as first-line treatment for this disease cannot be given as part of a clinical trial.
- Patients that have received prior radiation therapy in any setting for this disease are eligible.
- Adults age ≥ 18 years.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Group 1
Osimertinib
|
Single agent Osimertinib by mouth once daily.
Dosing and administration of osimertinib will be administered as per routine standard of care per the package insert or per institutional guidelines.
Other Names:
|
|
Group 2
Osimertinib + Chemotherapy
|
Osimertinib by mouth once daily + Chemotherapy.
Chemotherapy choice will be per treating physician.
Dosing and administration of osimertinib +/- chemotherapy agents will be administered as per routine standard of care per the package insert or per institutional guidelines.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
real-world Progression-Free Survival (rwPFS)
Time Frame: From initiation of therapy to progression or death, up to 3 years
|
Time from initiating therapy to progression or death without documented progression
|
From initiation of therapy to progression or death, up to 3 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
real-world Overall Survival (rwOS)
Time Frame: From initiation of therapy to death, up to 3 years
|
Time from initial therapy to death from any cause.
|
From initiation of therapy to death, up to 3 years
|
|
real-world time to treatment discontinuation (rwTTD)
Time Frame: From initiation of therapy to discontinuation of osimertinib, up to 3 years
|
Time from treatment initiation (osimertinib or osimertinib + chemotherapy) to discontinuation of osimertinib.
|
From initiation of therapy to discontinuation of osimertinib, up to 3 years
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient-Reported Outcomes (PRO)
Time Frame: 3 years
|
Functional Assessment of Cancer Therapy-G7+1 Version 4 (FACT-G7+1)
|
3 years
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Chair: Suzanne Cole, MD, UT Southwestern Simmons Comprehensive Cancer Center
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Neoplasms by Site
- Neoplasms
- Respiratory Tract Diseases
- Lung Diseases
- Respiratory Tract Neoplasms
- Thoracic Neoplasms
- Carcinoma, Bronchogenic
- Bronchial Neoplasms
- Lung Neoplasms
- Carcinoma, Non-Small-Cell Lung
- Amino Acids, Peptides, and Proteins
- Organic Chemicals
- Heterocyclic Compounds
- Heterocyclic Compounds, 2-Ring
- Heterocyclic Compounds, Fused-Ring
- Therapeutics
- Inorganic Chemicals
- Chlorine Compounds
- Nitrogen Compounds
- Coordination Complexes
- Guanine
- Hypoxanthines
- Purinones
- Purines
- Glutamates
- Amino Acids, Acidic
- Amino Acids
- Amino Acids, Dicarboxylic
- Platinum Compounds
- Pemetrexed
- Carboplatin
- Cisplatin
- Drug Therapy
- osimertinib
Other Study ID Numbers
- PrE1702
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.